logo.jpg
Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors
September 19, 2024 08:00 ET | Helsinn Healthcare S.A.
Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors Lugano, Switzerland – September 19, 2024 – Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of...
logo.png
CSL schließt sich Accumulus Synergy an, um den Wandel der Branche voranzutreiben
September 17, 2024 09:05 ET | Accumulus Synergy
BURLINGAME, Kalifornien, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy, Inc. („Accumulus“) und seine Gründungssponsoren sind stolz darauf, CSL als erstes Mitgliedsunternehmen begrüßen zu...
logo.png
CSL rejoint Accumulus Synergy pour faire évoluer le secteur
September 17, 2024 09:05 ET | Accumulus Synergy
BURLINGAME, Californie, 17 sept. 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy, Inc. (« Accumulus »), et ses sponsors fondateurs sont fiers d’accueillir CSL en tant que première organisation membre....
logo.png
CSL Joins Accumulus Synergy to Drive Industry Change
September 17, 2024 09:05 ET | Accumulus Synergy
BURLINGAME, Calif., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy, Inc. (“Accumulus”), and its Founding Sponsors are proud to welcome CSL as its first member organization. This collaboration...
Can-Fite BioPharma Logo.jpg
Can-Fite: Pancreatic Carcinoma Phase IIa Clinical Study with Namodenoson Received Regulatory Authorization from the Israeli Ministry of Health
September 16, 2024 07:00 ET | Can-Fite BioPharma Ltd.
Study will aim to establish safety and clinical efficacy PETACH TIKVA, Israel, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology...
blue-mountain-logo-blue 1 1.png
Blue Mountain and RCM Technologies Partner to Elevate Enterprise Asset Management in Life Sciences with Pre-Validated Software and Unparalleled Domain Expertise
September 05, 2024 09:00 ET | Blue Mountain
Blue Mountain & RCM Technologies join forces to deliver cutting-edge EAM solutions, tailored for life sciences with pre-validated software & expert service
YSEOP_LOGO_FINAL-PURPLE-_-YELLOW (1).png
Yseop Joins Veeva’s AI Partner Program to Accelerate Regulatory Document Writing and AI-Driven Content Automation
September 05, 2024 09:00 ET | Yseop
NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Yseop, a leader in artificial intelligence (AI) enterprise software, is excited to announce it has joined the Veeva AI Partner Program. As a Veeva AI...
Cellectis Logo.png
Monthly information on share capital and company voting rights
September 04, 2024 16:30 ET | Cellectis Inc.
PARIS, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number of sharesin the capitalTotal number of voting...
Can-Fite BioPharma Logo.jpg
Can-Fite Reports First Half 2024 Financial Results & Progress in Two Pivotal Phase III Clinical Studies
August 29, 2024 08:15 ET | Can-Fite BioPharma Ltd.
RAMAT GAN, Israel, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that...
wuFVh3u3_400x400.jpg
Inaugural Pre-JPM Partnering Week to Wrap Up 2024, Prepare for 2025
August 29, 2024 07:30 ET | Big4Bio
New life science partnering conference to debut that prepares and helps industry dealmakers and stakeholders for the JP Morgan Healthcare Conference week